The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call
The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call
CERRITOS, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC ("TOI") (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter 2023 financial results after the market close on Wednesday, November 8, 2023, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
加利福尼亚州塞里托斯,2023年10月18日(Global Newswire)--美国最大的价值型肿瘤学组织之一肿瘤研究所(TOI)(纳斯达克代码:TOI)今天宣布,该公司将在2023年11月8日(星期三)股市收盘后公布2023年第三季度财务业绩,随后将于当天下午5点召开电话会议。(东部时间)。
The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13741314. The replay will be available until November 15, 2023.
拨打1-877-407-0789或拨打国际电话号码1-201-689-8562,即可现场收听电话会议。重播将在通话两小时后进行,可通过拨打1-844-512-2921收听重播,或拨打国际电话1-412-317-6671收听重播。现场通话和重播的密码是13741314。重播将持续到2023年11月15日。
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at
感兴趣的投资者和其他各方也可以登录公司网站的投资者关系部分收听电话会议的同步网络直播,网址为:
About The Oncology Institute
关于肿瘤学研究所
Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 100+ employed clinicians and more than 800 teammates in over 65 clinic locations and growing, TOI is changing oncology for the better. For more information visit .
成立于2007年的希望与创新肿瘤学研究所(TOI)通过在社区环境中提供高度专业化的、基于价值的癌症护理来推动肿瘤学的发展。TOI为180多万患者提供基于证据的尖端癌症护理,包括临床试验、输血和其他传统上与最先进的护理提供机构相关的护理提供模式。TOI拥有100多名受雇的临床医生和超过65个诊所的800多名队友,而且还在不断增长,TOI正在让肿瘤学变得更好。有关更多信息,请访问。
Investors
投资者
Solebury Strategic Communications
investors@theoncologyinstitute.com
索尔伯里战略通信
邮箱:Investors@theoncologyInstitute te.com